Although Rac is considered to antagonize RhoA, studies suggest that RACGAP1 can keep Rac or RhoA activated in different cancers, and the subsequent events of Rac and RhoA activation are not always irrelevant, implying that RACGAP1 can coordinate Rac and RhoA in some situations. The gene discussed is AKT1; the disease is cancer.